ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
The suspension is an opalescent, colourless to pale brownish liquid. 4. CLINICAL PARTICULARS . 4.1 Therapeutic indications Shingrix is indicated for prevention of herpes zoster (HZ) and post-herpetic neuralgia (PHN), in: ... As a precautionary measure, it is preferable to avoid the use of Shingrix during pregnancy. ...
Product, Summary, Characteristics, Suspension, Summary of product characteristics, Precautionary
Download ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Product, Management, Lifecycle, Product lifecycle management
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guidelines, Good, Practices, Clinical, Good clinical practice e6
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
Guidelines, European, Agency, Medicine, Harmonised, European medicines agency, Ich harmonised
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Product, Medicinal, Traditional, Herbal, Products1 traditional herbal medicinal products, Products1
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Good, Practices, Pharmaceutical, Manufacturing, Active, Ingredients, Good manufacturing practice for active, Good manufacturing practice for active pharmaceutical ingredients
Related documents
SA Civil Aviation Authority 1685 Website: www.caa.co
caa.co.za1 MEDIA STATEMENT 13 March 2022 CIVIL AVIATION AUTHORITY CONFIRMS THE INDEFINITE SUSPENSION OF COMAIR’S AIR OPERATOR CERTIFICATE Johannesburg – Following the 24hour precautionary suspension of Comair PTY Ltd.’s Air Operator Certificate (AOC) privileges on Saturday morning 12 March 2022, the South African Civil Aviation
SANTA CRUZ BIOTECHNOLOGY, INC. Protein A/G PLUS …
datasheets.scbt.comDec 11, 2017 · SANTA CRUZ BIOTECHNOLOGY, INC. Protein A/G PLUS-Agarose: sc-2003 Santa Cruz Biotechnology, Inc. 1.800.457.3801 831.457.3800 fax 831.457.3801 Europe +00800 4573 8000 49 6221 4503 0 www.scbt.com PRODUCT Protein A/G PLUS is provided as an agarose conjugate for use in immunopre-
After Action Report/Improvement Plan - Centers for Disease …
emergency.cdc.gov[Protective Marking] Homeland Security Exercise and Evaluation Program (HSEEP) After Action Report/Improvement Plan [Full Exercise Name] (AAR/IP) [Exercise Name Continued]
T51002 Hendrickson TIREMAX® PRO and CP Installation, …
www.hendrickson-intl.comincludes important preparation, precautionary and safety information pertaining to the procedures included in this document. to help prevent personal injury and equipment damage; warnings, cautions and other relative ... suspension / trailer (e.g., road side, front axle, rear axle, curb side rear, etc.).
L496 Standard Wheel-End Maintenance Procedures
www.hendrickson-intl.comprecautionary statements, refer to Hendrickson literature number T12007, available at www Hendrickson-intl com/TrailerLit noTe: do noT service a suspension or any components that is under warranty without first contacting Hendrickson Technical Services Refer to CONTACTING HENDRICKSON for details